The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Iadademstat in combination with gilteritinib for patients with mutated FLT3 relapsed/refractory acute myeloid leukemia.
 
Amir Tahmasb Fathi
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Autolus; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; EnClear Therapies; FORMA Therapeutics; Genentech; Immunogen; Ipsen; Kite, a Gilead company; Mablytics; MorphoSys; Novartis; Orum Therapeutics; Pfizer; PureTech; Rigel; SERVIER; Takeda
Research Funding - Abbvie (Inst); agios (Inst); Bristol-Myers Squibb (Inst); SERVIER (Inst)
 
Mabel Arévalo
Employment - Oryzon Genomics
 
Sonia Gutierrez
Employment - Oryzon Genomics
 
Antonieta Molero
Consulting or Advisory Role - Oryzon Genomics
 
Natalia Sacilotto
Employment - Oryzon Genomics
 
Ana E. Limon
Employment - Oryzon Genomics; Tango Therapeutics (I)
Stock and Other Ownership Interests - BMS GmbH & Co. KG (I); Oryzon Genomics; Tango Therapeutics (I); Viracta Therapeutics
Consulting or Advisory Role - Oryzon Genomics
Patents, Royalties, Other Intellectual Property - Tango Therapeutics (I)
 
Douglas V. Faller
Employment - Oryzon Genomics; Phoenicia Biosciences; Viracta Therapeutics
Leadership - Briacell; Oryzon Genomics; Phoenicia Biosciences; Viracta Therapeutics
Stock and Other Ownership Interests - Briacell; Cytea Bio; Faller Williams LLC; Oryzon Genomics; Phoenicia Biosciences; Takeda; Viracta Therapeutics
Consulting or Advisory Role - Briacell; Cytea Bio; Molecular Partners; Oryzon Genomics; WuXi Biologics
Patents, Royalties, Other Intellectual Property - Faller Williams; Phoenicia Biosciences; Viracta Therapeutics